相似文献
1
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.
Nanomedicine (Lond). 2010 Jul;5(5):793-806. doi: 10.2217/nnm.10.50.
2
Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
J Drug Target. 2013 Feb;21(2):107-25. doi: 10.3109/1061186X.2012.712130. Epub 2012 Aug 9.
3
Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
ACS Appl Mater Interfaces. 2021 Dec 1;13(47):55913-55927. doi: 10.1021/acsami.1c17917. Epub 2021 Nov 16.
4
A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
Nanomedicine (Lond). 2014 May;9(6):877-94. doi: 10.2217/nnm.14.41.
5
Design of Targeted Nanostructured Coordination Polymers (NCPs) for Cancer Therapy.
Molecules. 2020 Jul 29;25(15):3449. doi: 10.3390/molecules25153449.
6
Dendronized Systems for the Delivery of Chemotherapeutics.
Adv Cancer Res. 2018;139:85-120. doi: 10.1016/bs.acr.2018.04.003. Epub 2018 May 18.
7
Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution.
Nano Lett. 2012 Apr 11;12(4):2165-70. doi: 10.1021/nl300630c. Epub 2012 Mar 19.
8
Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin.
J Control Release. 2024 May;369:351-362. doi: 10.1016/j.jconrel.2024.03.046. Epub 2024 Apr 3.
9
Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Arch Pharm Res. 2018 Feb;41(2):111-129. doi: 10.1007/s12272-017-0995-x. Epub 2017 Dec 6.
10
Polymer nanoparticles--a novel strategy for administration of Paclitaxel in cancer chemotherapy.
Curr Med Chem. 2012;19(36):6207-13.
引用本文的文献
1
Therapeutic impacts of GNE‑477‑loaded HO stimulus‑responsive dodecanoic acid‑phenylborate ester‑dextran polymeric micelles on osteosarcoma.
Int J Mol Med. 2024 Aug;54(2). doi: 10.3892/ijmm.2024.5393. Epub 2024 Jun 28.
2
Engineered rare-earth nanomaterials for fluorescence imaging and therapy.
RSC Adv. 2023 Sep 14;13(39):27512-27519. doi: 10.1039/d3ra02503a. eCollection 2023 Sep 8.
3
Theoretical aspects of interaction of the anticancer drug cytarabine with human serum albumin.
Struct Chem. 2023 Mar 29:1-9. doi: 10.1007/s11224-023-02164-6.
4
Novel archetype in cancer therapeutics: exploring prospective of phytonanocarriers.
3 Biotech. 2022 Nov;12(11):324. doi: 10.1007/s13205-022-03372-3. Epub 2022 Oct 15.
5
Preparation and Characteristics of Alginate Microparticles for Food, Pharmaceutical and Cosmetic Applications.
Polymers (Basel). 2022 Sep 14;14(18):3834. doi: 10.3390/polym14183834.
6
Polymeric Nanosystems Applied for Metal-Based Drugs and Photosensitizers Delivery: The State of the Art and Recent Advancements.
Pharmaceutics. 2022 Jul 20;14(7):1506. doi: 10.3390/pharmaceutics14071506.
7
Cancer cell membrane-camouflaged MOF nanoparticles for a potent dihydroartemisinin-based hepatocellular carcinoma therapy.
RSC Adv. 2020 Feb 18;10(12):7194-7205. doi: 10.1039/c9ra09233a. eCollection 2020 Feb 13.
8
Targeting non-coding RNAs to overcome cancer therapy resistance.
Signal Transduct Target Ther. 2022 Apr 13;7(1):121. doi: 10.1038/s41392-022-00975-3.
9
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs.
ACS Nano. 2022 Apr 26;16(4):5184-5232. doi: 10.1021/acsnano.2c01252. Epub 2022 Mar 29.
10
Amino Acids, Peptides, and Proteins: Implications for Nanotechnological Applications in Biosensing and Drug/Gene Delivery.
Nanomaterials (Basel). 2021 Nov 8;11(11):3002. doi: 10.3390/nano11113002.
本文引用的文献
1
Morphing low-affinity ligands into high-avidity nanoparticles by thermally triggered self-assembly of a genetically encoded polymer.
ACS Nano. 2010 Apr 27;4(4):2217-27. doi: 10.1021/nn901732h.
2
Controlled radio-frequency hyperthermia using an MR scanner and simultaneous monitoring of temperature and therapy response by (1)H, (23)Na and (31)P magnetic resonance spectroscopy in subcutaneously implanted 9L-gliosarcoma.
Int J Hyperthermia. 2010 Feb;26(1):79-90. doi: 10.3109/02656730903373509.
3
Nanomaterial standards for efficacy and toxicity assessment.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jan-Feb;2(1):99-112. doi: 10.1002/wnan.66.
4
In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.
Integr Biol (Camb). 2009 Jun;1(5-6):382-93. doi: 10.1039/b904890a. Epub 2009 May 11.
5
Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection.
Nat Mater. 2009 Dec;8(12):993-9. doi: 10.1038/nmat2569. Epub 2009 Nov 8.
6
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.
J Clin Oncol. 2009 Nov 1;27(31):5287-97. doi: 10.1200/JCO.2009.23.5556. Epub 2009 Sep 8.
7
Release of liposomal contents by cell-secreted matrix metalloproteinase-9.
Bioconjug Chem. 2009 Jul;20(7):1332-9. doi: 10.1021/bc9000646.
8
Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Mol Pharm. 2009 Sep-Oct;6(5):1562-72. doi: 10.1021/mp9001206.
9
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer.
Int J Nanomedicine. 2009;4:99-105. doi: 10.2147/ijn.s3061. Epub 2009 Apr 20.
10
Preclinical and clinical studies of anticancer agent-incorporating polymer micelles.
Cancer Sci. 2009 Apr;100(4):572-9. doi: 10.1111/j.1349-7006.2009.01103.x.
Zotero 插件